UltraMIST® Low-Frequency Ultrasound Therapy
Sanuwave UltraMIST® · delivered by Apollo Wound Care
UltraMIST delivers low-energy, low-frequency (40 kHz) ultrasound to the wound bed through a gentle saline mist — without ever touching the wound surface. The acoustic waves mechanically stimulate cells in and below the wound, supporting the body's natural healing cascade. Because nothing contacts the wound, treatment is painless, which makes it especially suited to sensitive wounds and patients who can't tolerate contact-based therapies. Apollo Wound Care brings UltraMIST to the home as an adjunct to your wound-care plan when standard care has stalled.
Three measurable effects on the wound.
Reduce bacterial load
Acoustic disruption reduces bacteria and biofilm at the wound surface, lowering an infection-related barrier to healing.
Calm inflammation
Mechanical stimulation modulates the local inflammatory response, helping chronic wounds progress past a stalled inflammatory phase.
Increase perfusion
Improved blood flow and angiogenic signaling support granulation tissue and oxygen delivery to the wound bed.
See a treatment, start to finish.
A simplified cross-section of what non-contact ultrasound does at the wound bed. It loops automatically — or step through it yourself.
A fine saline mist carries acoustic energy to the wound. Nothing touches the surface.
The problem it exists to solve.
Some wounds cannot tolerate being touched. A painful venous ulcer, a fresh graft site, a deep-tissue pressure injury on fragile skin — for these, every contact-based treatment carries a cost, and the predictable result is that treatment gets skipped, shortened or refused. UltraMIST is the only modality in this bag that reaches the wound bed without touching it, which makes it the answer when pain itself is the reason a wound is not being treated properly.
Treatment a patient will actually accept
Because nothing contacts the wound, there is no procedural pain to dread and no reason to postpone a session. Treatment that gets tolerated is treatment that gets completed.
Three barriers addressed at once
Bacteria and biofilm, stalled inflammation and poor perfusion are three of the most common reasons a wound stops closing — and this addresses all three in a single short session.
It layers onto the plan, not over it
It runs alongside your dressings, compression and debridement rather than replacing them, so nothing already working has to be given up to add it.
Short enough to fit a home visit
Three to twenty minutes per session, two to three times a week — a cadence that is realistic at the bedside and does not depend on you travelling anywhere.
In plain language.
- Nothing touches the wound, so there is no procedural pain during treatment.
- Each session is short — most take between three and twenty minutes.
- It works alongside your existing dressings and care plan, not instead of them.
- Used for venous leg ulcers, diabetic foot ulcers, deep-tissue pressure injuries, surgical wounds and soft-tissue injuries.
Mechanism reference: Serena TE. Ostomy Wound Management. 2009;55(1):22–30. UltraMIST is an adjunctive treatment for acute and chronic wounds. Contraindicated over cancer lesions, electrical implants (e.g., pacemakers), and the pregnant uterus. Candidacy and coverage are determined at clinical assessment.
Your wound won't wait. Neither do we.
One phone call covers everything: the wound, your insurance, and the first visit date. Family members and referring providers are welcome to call on a patient's behalf.
Mon–Sat, 8am–6pm · New York City — Manhattan, Brooklyn, Queens, The Bronx & Staten Island